We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

RXi Pharmaceuticals Appoints H. Paul Dorman and Curtis Lockshin, Ph.D. to Board of Directors

News   Apr 23, 2013

 
RXi Pharmaceuticals Appoints H. Paul Dorman and Curtis Lockshin, Ph.D. to Board of Directors
 
 
 

RELATED ARTICLES

Gene Therapy Reduces Obesity and Reverses Metabolic Disease in Mice

News

In a study published in Genome Research, researchers developed a gene therapy that specifically reduces fat tissue and reverses obesity-related metabolic disease in obese mice.

READ MORE

World-first: Genetically Modified Miniature Human Livers Are Grown in the Laboratory

News

Researchers are the first to grow genetically modified miniature human livers in the laboratory, to emulate human liver disease progression and test therapeutics.

READ MORE

Unraveling the Genetic Secrets of the Glacier Ice Worm

News

Researchers uncover factors underlying the genetic structure of glacier ice worms.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE